Drugs / Tobacco Cigarette
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT07694466 Comparator | Sep 2026 → Feb 2027 expected | — | Hannah Harris | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tobacco Cigarette | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07694466 ↗ |
| Known as | Marlboro Gold | “A leading brand of tobacco cigarette (\~1.0 gram; Marlboro Gold; Phillip Morris International)” NCT07694466 ↗ |
| Route | Inhaled | “Participants will inhale a leading brand of tobacco cigarette” NCT07694466 ↗ |